glp-1 cancer GLP-1RA and thyroid cancer: New study suggests detection bias, not causation The science around GLP-1 drugs

Des scientifiques ont constat de faibles taux de NAD+ chez les patients atteints d'Alzheimer, de Parkinson et de sclrose en plaques

Animal models of traumatic brain injury show reduced lesion volume and improved behavioral outcomes following BPC-157 administration

244 Therefore, a complex regulatory mechanism may underlie the modulation of TMAO metabolism by statins, necessitating further research to clarify the precise pathways involved and their clinical implications (Table 8)

We can challenge pharmaceutical companies about their prices rather than cutting off patients. Health disparities and long-term impact Higher rates of obesity are observed among low-income Rhode Islanders and communities of color

F.Al TarabshehT